Anti-Inflammatory Effects of SGLT2 Inhibitors: Focus on Macrophages

Updated insights into the molecular networks for NLRP3 inflammasome activation

Empagliflozin alleviates atherosclerotic calcification by inhibiting osteogenic differentiation of vascular smooth muscle cells

MCC950, a Selective NLRP3 Inhibitor, Attenuates Adverse Cardiac Remodeling Following Heart Failure Through Improving the Cardiometabolic Dysfunction in Obese Mice